Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-27T05:10:04.874Z Has data issue: false hasContentIssue false

Foreword: Towards markers for anthelmintic resistance in helminths of importance in animal and human health

Published online by Cambridge University Press:  03 July 2007

R. K. PRICHARD*
Affiliation:
Institute of Parasitology, McGill University, 21111 Lakeshore Road, Ste-Anne-de-Bellevue, Quebec, Canada, H9X 3V9
G. von SAMSON-HIMMELSTJERNA
Affiliation:
Institute for Parasitology, University of Veterinary Medicine Foundation, Bünteweg 17, Hannover30559, Germany
W. J. BLACKHALL
Affiliation:
Institute for Parasitology, University of Veterinary Medicine Foundation, Bünteweg 17, Hannover30559, Germany
T. G. GEARY
Affiliation:
Institute of Parasitology, McGill University, 21111 Lakeshore Road, Ste-Anne-de-Bellevue, Quebec, Canada, H9X 3V9
*
*Corresponding author: Institute of Parasitology, McGill University, 21111 Lakeshore Road, Ste-Anne-de-Bellevue, Quebec, Canada, H9X 3V9. Tel: +1-514-398-7729. Fax: +1-514-398-7857. E-mail: roger.prichard@mcgill.ca

Summary

Anthelmintic resistance is a serious problem in veterinary medicine and appears to be developing in some helminths of importance to human health. Anthelmintic drugs remain the principal means of control of helminth infections in animals and humans and the continued dependence on these pharmaceuticals will continue to impose selection pressure for resistance development. Our ability to detect anthelmintic resistance before control breaks down and to monitor the spread of anthelmintic resistance is quite limited. We are currently dependent on biological methods which are not sufficiently sensitive to detect low levels of drug resistance and are particularly difficult to perform on helminth parasites of humans. There is a serious need for new molecular markers for detecting and monitoring for anthelmintic resistance. The problem of anthelmintic resistance is already very serious in nematode parasites of livestock. In addition, there should be great concern about possible anthelmintic resistance development and the lack of tools and efforts for monitoring it as part of the major worldwide programmes to control helminth parasites in people. An international Consortium has been formed to develop Anthelmintic Resistance Single nucleotide polymorphism markers (CARS). Discussions within the Consortium have addressed the need for such markers, the current state of knowledge about them, possible mechanisms of anthelmintic resistance and approaches and constraints to the development of markers. Summaries of the state of the art in these areas are presented in a series of papers in this Special Issue of Parasitology.

Type
Research Article
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Albonico, M., Bickle, Q., Ramsan, M., Montresor, A., Savioli, L. and Taylor, M. (2003). Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bulletin of the World Health Organization, 81, 343352.Google ScholarPubMed
Albonico, M., Engels, D. and Savioli, L. (2004). Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth control. International Journal for Parasitology 34, 12051210.CrossRefGoogle ScholarPubMed
Brennan, G.P, Fairweather, I., Trudgett, A., Hoey, E., McCoy, S. W., McConville, M., Meaney, M., Robinson, M., McFerran, N., Ryan, L., Lanusse, C., Mottier, L., Alvarez, L., Solana, H., Virkel, G. and Brophy, P. M. (2007). Understanding triclabendazole resistance. Experimental and Molecular Pathology 82, 104109.CrossRefGoogle ScholarPubMed
Coles, G. C., Jackson, F., Pomroy, W. E., Prichard, R. K., von Samson-Himmelstjerna, G., Silvestre, A., Taylor, M. A. and Vercruysse, J. (2006). The detection of anthelmintic resistance in nematodes of veterinary importance. Veterinary Parasitology 136, 167185.CrossRefGoogle ScholarPubMed
De Clercq, D., Sacko, M., Behnke, J., Gilbert, F., Dorny, P. and Vercruysse, J. (1997). Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali. American Journal of Tropical Medicine and Hygiene, 57, 2530.CrossRefGoogle ScholarPubMed
Fenwick, A. and Webster, J. P. (2006). Schistosomiasis: challenges for control, treatment and drug resistance. Current Opinions in Infectious Diseases 19, 577582.CrossRefGoogle ScholarPubMed
Kaplan, R. M. (2004). Drug resistance in nematodes of veterinary importance: a status report. Trends in Parasitology 20, 477481.CrossRefGoogle ScholarPubMed
Osei-Atweneboana, M. Y., Eng, J. K. L., Boakye, D. A., Gyapong, J. O. and Prichard, R. K. (2007). Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two phase epidemiological study. Lancet (in press).CrossRefGoogle Scholar
Prichard, R. K. (2001). Genetic variability following selection of Haemonchus contortus with anthelmintics. Trends in Parasitology 17, 445453.CrossRefGoogle ScholarPubMed
von Samson-Himmelstjerna, G. and Blackhall, W. (2005). Will technology provide solutions for drug resistance in veterinary helminths? Veterinary Parasitology 132, 223239.CrossRefGoogle ScholarPubMed
Wolstenholme, A. J., Fairweather, I., Prichard, R., von Samson-Himmelstjerna, G. and Sangster, N. C. (2004). Drug resistance in veterinary helminths. Trends in Parasitology 20, 469476.CrossRefGoogle ScholarPubMed